Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Lancet. Infectious Diseases (Print)

• Publication date

  2017-11-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/S1473-3099(17)30304-3PMID 28774702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Invasive Candidiasis.

  2019cited by this paper
• Values of radiological examinations for the diagnosis and prognosis of invasive bronchial‐pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary diseases

  2018cited by this paper
• Comparison of Amphotericin B Bladder Irrigations Versus Fluconazole for the Treatment of Candiduria in Intensive Care Unit Patients

  2017cited by this paper
• Commercial Molecular Tests for Fungal Diagnosis from a Practical Point of View.

  2017cited by this paper
• Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

  2016cited by this paper
• Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis.

  2016cited by this paper
• Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

  2016cited by this paper
• Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program

  2016cited by this paper
• Problematic Dichotomization of Risk for Intensive Care Unit (ICU)-Acquired Invasive Candidiasis: Results Using a Risk-Predictive Model to Categorize 3 Levels of Risk From a Multicenter Prospective Cohort of Australian ICU Patients.

  2016cited by this paper
• Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

  2016cited by this paper
• Invasive Aspergillosis Associated With Severe Influenza Infections

  2016cited by this paper
• Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF).

  2016cited by this paper
• ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo

  2016cited by this paper
• Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units

  2016cited by this paper
• Clinical utility of panfungal polymerase chain reaction for the diagnosis of invasive fungal disease: a single center experience.

  2016cited by this paper
• Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.

  2016cited by this paper
• Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan.

  2016cited by this paper
• Discrimination of Aspergillosis, Mucormycosis, Fusariosis, and Scedosporiosis in Formalin-Fixed Paraffin-Embedded Tissue Specimens by Use of Multiple Real-Time Quantitative PCR Assays

  2016cited by this paper
• Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.

  2016cited by this paper
• Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions

  2016cited by this paper
• Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study.

  2015cited by this paper
• T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.

  2015cited by this paper
• High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan

  2015cited by this paper
• High diversity of non‐sporulating moulds in respiratory specimens of immunocompromised patients: should all the species be reported when diagnosing invasive aspergillosis?

  2015cited by this paper
• Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA

  2015cited by this paper
• Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing

  2015cited by this paper
• Molecular diagnostic methods for invasive fungal disease: the horizon draws nearer?

  2015cited by this paper
• A Randomized, Placebo-controlled Trial of Preemptive Antifungal Therapy for the Prevention of Invasive Candidiasis Following Gastrointestinal Surgery for Intra-abdominal Infections

  2015cited by this paper
• Antifungal stewardship in a tertiary-care institution: a bedside intervention.

  2015cited by this paper
• Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality.

  2015cited by this paper
• Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia

  2015cited by this paper
• Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus

  2015cited by this paper
• Using immunohistochemistry to assess the accuracy of histomorphologic diagnosis of aspergillosis and mucormycosis.

  2015cited by this paper
• Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031).

  2015cited by this paper
• Invasive mould sinusitis in patients with haematological malignancies: a 10 year single-centre study.

  2015cited by this paper
• Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.

  2015cited by this paper
• (18)F-FDG PET/CT contribution to diagnosis and treatment response of rhino-orbital-cerebral mucormycosis.

  2015cited by this paper
• A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality

  2015cited by this paper
• High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies.

  2015cited by this paper
• Echinocandin Resistance in Candida.

  2015cited by this paper
• Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: A systematic review and meta-analysis

  2015cited by this paper
• Antifungal stewardship in daily practice and health economic implications

  2015cited by this paper
• Incidence, characteristics and outcome of ICU-acquired candidemia in India

  2015cited by this paper
• Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes

  2015cited by this paper
• Complications of Candidemia in ICU Patients: Endophthalmitis, Osteomyelitis, Endocarditis

  2015cited by this paper
• An In-House Assay Is Superior to Sepsityper for Direct Matrix-Assisted Laser Desorption Ionization–Time of Flight (MALDI-TOF) Mass Spectrometry Identification of Yeast Species in Blood Cultures

  2015cited by this paper
• Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

  2014cited by this paper
• Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period

  2014cited by this paper
• Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU*

  2014cited by this paper
• Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010)

  2014cited by this paper
• FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.

  2014cited by this paper
• Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing

  2014cited by this paper
• Prospective evaluation of the cost of diagnosis and treatment of invasive fungal disease in a cohort of adult haematology patients in the UK.

  2014cited by this paper
• MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.

  2014cited by this paper
• ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.

  2014cited by this paper
• Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study.

  2014cited by this paper
• Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.

  2014cited by this paper
• Global trends in the distribution of Candida species causing candidemia.

  2014cited by this paper
• How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach.

  2014cited by this paper
• Undiagnosed invasive candidiasis: incorporating non-culture diagnostics into rational prophylactic and preemptive antifungal strategies

  2014cited by this paper
• Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care.

  2013cited by this paper
• A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts

  2013cited by this paper
• Reduced-intensity conditioning regimen with low-dose ATG-F for unrelated bone marrow transplant is associated with lower non-relapse mortality than a regimen with low-dose TBI: a single-center retrospective analysis of 103 cases

  2013cited by this paper
• β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis.

  2013cited by this paper
• Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial.

  2013cited by this paper
• Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil.

  2013cited by this paper
• Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes

  2013cited by this paper
• Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20‐year autopsy study

  2013cited by this paper
• A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients.

  2012cited by this paper
• Risk stratification for invasive aspergillosis in immunocompromised patients

  2012cited by this paper
• Adherence to recommendations for the use of antifungal agents in a tertiary care hospital.

  2012cited by this paper
• ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

  2012cited by this paper
• β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).

  2012cited by this paper
• Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata

  2012cited by this paper
• Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.

  2012cited by this paper
• ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).

  2012cited by this paper
• Opportunistic fungal infections in the Asia-Pacific region.

  2012cited by this paper
• Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.

  2012cited by this paper
• New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis

  2012cited by this paper
• Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis

  2012cited by this paper
• β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study

  2012cited by this paper
• Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).

  2011cited by this paper
• Fungal pneumonia in patients with hematologic malignancies: current approach and management

  2011cited by this paper
• European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

  2011cited by this paper
• How I treat mucormycosis.

  2011cited by this paper
• Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007).

  2011cited by this paper
• Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: a prospective study

  2011cited by this paper
• Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

  2010cited by this paper
• Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.

  2010cited by this paper
• Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

  2009cited by this paper
• Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome

  2008cited by this paper
• Factors associated with overall and attributable mortality in invasive aspergillosis.

  2008cited by this paper
• To treat or not to treat – critically ill patients with candiduria

  2008cited by this paper
• Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp.

  2008cited by this paper
• Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.

  2008cited by this paper
• A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates.

  2008cited by this paper
• Infection with Scedosporium apiospermum and S. prolificans, Australia

  2007cited by this paper
• Fusarium Infections in Immunocompromised Patients

  2007cited by this paper
• Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis.

  2006cited by this paper
• Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003).

  2006cited by this paper

• Concurrent pulmonary aspergillosis and phaeohyphomycosis due to Verruconis spp. in a stem cell transplant recipient with chronic graft-versus-host disease

  2026cites this paper
• Performance Evaluation of the Chemiluminescence Immunoassay for Quantitative Detection of (1, 3)-β-D-glucan for Diagnosis of Invasive Fungal Diseases.

  2026cites this paper
• Can Artificial Intelligence Optimize the Early Diagnosis of Invasive Candidiasis? A Systematic Review and Meta-Analysis.

  2026cites this paper
• In vitro activity of eight antifungal drugs against clinical and hospital isolates of Candida parapsilosis complex; a multicenter study, 2023–2024

  2026cites this paper
• Real-World Experience with Isavuconazole for Invasive Aspergillosis in Hematologic Patients with and Without COVID-19 in Brazil

  2025cites this paper
• Repurposing tafenoquine as a potent antifungal agent against Candida haemulonii sensu stricto.

  2025cites this paper
• Role of liposomal amphotericin B in intensive care unit: an expert opinion paper

  2025cites this paper
• Clinical Significance of Aspergillus sp Found in Respiratory Fungal Cultures of ICU Patients

  2025cites this paper
• Whole genome sequencing analysis of Candida glabrata isolates collected from patients with selected drug-resistant candidiasis hospitalized in Eastern Poland.

  2025cites this paper
• Efficacy and Safety of Amphotericin B Colloidal Dispersion via Nebulized Inhalation Combined with Intravenous Therapy for Invasive Pulmonary Fungal Disease: A Single-Center, Retrospective Cohort Study

  2025cites this paper
• In Vitro Activity of Antifungals in Combination With Meropenem or Daptomycin Against Dual Candida albicans–Bacterial Biofilms

  2025cites this paper
• Pentraxin 3 as a Potential Biomarker of Invasive Fusariosis in Onco‐Haematological Patients

  2025cites this paper
• Pulmonary Aspergillosis in Immunocompromised Critically Ill Patients: Prevalence, Risk Factors, Clinical Features and Diagnosis—A Narrative Review

  2025influential citation
• Medical Mycology Education in Brazil: A Cross-Sectional Survey of Medical Schools

  2025cites this paper
• Candidemia caused by Meyerozyma guilliermondii species complex in patients with cancer: A systematic review of case reports.

  2025cites this paper
• Genomic Insights into Azole Resistance Mechanisms in Candida tropicalis Among Hematological Malignancy Patients with Candidemia

  2025cites this paper
• Clinical features of influenza-associated pulmonary aspergillosis: a retrospective multicenter cohort study

  2025cites this paper
• Navigating therapeutic challenges: Voriconazole pharmacokinetics and CYP2C19 genetic polymorphism—A case report and literature review

  2025cites this paper
• Factors associated with beyond-therapeutic serum voriconazole trough level among critically ill patients with invasive fungal infections

  2025cites this paper
• Invasive candidiasis in critically ill patients: Fundamental concepts and future directions.

  2025cites this paper
• Aspergillus and the Lung

  2024cites this paper
• Rate, Risk Factors, and Outcomes of Invasive Fungal Infections in Patients with Hematologic Malignancies

  2024cites this paper
• Fungal Infections in Hospitalized Patients of Systemic Lupus Erythematosus: A United States Nationwide Cohort Analysis

  2024cites this paper
• Correlation between antifungal clinical practices and a new clinical decision support system ANTIFON-CLIC® for the treatment of invasive candidiasis: a retrospective multicentre study.

  2024cites this paper
• Candida albicans—A systematic review to inform the World Health Organization Fungal Priority Pathogens List

  2024cites this paper
• Clinical Characteristics of Candidemia Due to Candida parapsilosis with Serial Episodes: Insights from 5-Year Data Collection at a Tertiary Hospital in Korea

  2024cites this paper
• A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole

  2024cites this paper
• Challenges in the Management of Invasive Fungal Infections in the Middle East: Expert Opinion to Optimize Management Using a Multidisciplinary Approach

  2023cites this paper
• Pathogenic entero- and salivatypes harbour changes in microbiome virulence and antimicrobial resistance genes with increasing chronic liver disease severity

  2023influential citation
• Antifungal potency of clove ( Syzygium aromaticum ) essential oil extract against induced systemic infection by Candida albicans in mice

  2023cites this paper
• Candidemia in Adult Patients in the ICU: A Reappraisal of Susceptibility Testing and Antifungal Therapy

  2023cites this paper
• Phenotypic Array for Identification and Screening of Antifungals against Aspergillus Isolates from Respiratory Infections in KwaZulu Natal, South Africa

  2023cites this paper
• Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap.

  2023cites this paper
• Fungal Pathogens as Causes of Acute Respiratory Illness in Hospitalized Veterans: Frequency of Fungal Positive Test Results Using Rapid Immunodiagnostic Assays

  2023cites this paper
• Prognostic Trends and Current Challenges in Candidemia: A Comparative Analysis of Two Multicenter Cohorts within the Past Decade

  2023cites this paper
• Antifungal activity of 6-substituted amiloride and hexamethylene amiloride (HMA) analogs

  2023cites this paper
• Overcoming the On‐Target Toxicity in Antibody‐Mediated Therapies via an Indirect Active Targeting Strategy

  2023cites this paper
• Wood Metabolites of Myrcia insularis Gardner (Myrtaceae) have Potential Anti-Candida Activity

  2023cites this paper
• Trichoderma after crossing kingdoms: infections in human populations

  2023cites this paper
• Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study

  2023cites this paper
• Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape

  2023cites this paper
• Choice of initial antifungal therapy in critically Ill patients

  2022cites this paper
• Section 1. Colombian consensus on the diagnosis and follow-up of invasive aspergillosis and Aspergillus disease in adult and pediatric patients

  2022cites this paper
• Immunological and Enzymatic study of Staphylococcus aureus Bacteria and fungi isolated from oral cavity

  2022cites this paper
• A new bioinspired peptide on defensin from C. annuum fruits: Antimicrobial activity, mechanisms of action and therapeutical potential.

  2022cites this paper
• Invasive and Subcutaneous Infections Caused by Filamentous Fungi: Report from a Portuguese Multicentric Surveillance Program

  2022cites this paper
• Deep Fungal Infections Among General Hospital Inpatients in Southwestern China: A 5-Year Retrospective Study

  2022cites this paper
• Prospective comparison of (1,3)-beta-D-glucan detection using colorimetric and turbidimetric assays for diagnosing invasive fungal disease.

  2021cites this paper
• Diagnostic value of galactomannan test in non-immunocompromised critically ill patients with influenza-associated aspergillosis: data from three consecutive influenza seasons

  2021cites this paper
• Paving the Way to Overcome Antifungal Drug Resistance: Current Practices and Novel Developments for Rapid and Reliable Antifungal Susceptibility Testing

  2021cites this paper
• Fungal infections diagnosis – Past, present and future

  2021cites this paper
• Invasive fungal infections in acute and chronic liver impairment: A systematic review

  2021influential citation
• Epidemiology and risk of invasive fungal infections in systemic lupus erythematosus: a nationwide population-based cohort study

  2021cites this paper
• Impact of CYP2C19 genotype on voriconazole exposure and effect of voriconazole on the activity of CYP3A in patients with haematological malignancies

  2021cites this paper
• Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine

  2021cites this paper
• Pulmonary surfactant inactivation by β-D-glucan and protective role of surfactant protein A.

  2021cites this paper
• Emergence of resistant Candida glabrata in Germany

  2021cites this paper
• Clinical study of invasive pulmonary aspergillosis following influenza A H1N1

  2021cites this paper
• Micafungin for Candida infections in Slovenia and Romania: A multicenter, observational, prospective study.

  2021cites this paper
• Uncoupling of IL-6 signaling and LC3-associated phagocytosis drives immunoparalysis during sepsis.

  2021cites this paper
• Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?

  2021cites this paper
• Prognostic factors of Candida spp. bloodstream infection in adults: A nine-year retrospective cohort study across tertiary hospitals in Brazil and Spain

  2021cites this paper
• Biomaterials for the Prevention of Oral Candidiasis Development

  2021cites this paper
• Antimicrobial Activity of First-in-Class Antifungal, Manogepix, and Comparator Agents Testing against Contemporary Invasive Fungal Isolates from an International Surveillance Program (2018-2019): In Vitro Activity of Manogepix against Fungal Isolates.

  2021cites this paper
• Diagnosis of Invasive Candidiasis: A Narrative Review

  2021cites this paper
• Screening of chemical libraries for new antifungal drugs against Aspergillus fumigatus reveals the potential mechanism of action of miltefosine

  2021cites this paper
• Synergism of Zinc Oxide Quantum Dots with Antifungal Drugs: Potential Approach for Combination Therapy against Drug Resistant Candida albicans

  2021cites this paper
• A patient with hepatocellular carcinoma who developed invasive pulmonary aspergillosis after corticosteroid treatment

  2021cites this paper
• Management of Invasive Infections due to a Rare Arthroconidial Yeast, Saprochaete capitata, in Two Patients with Acute Hematological Malignancies

  2021cites this paper
• Characteristics and outcomes of patients with postoperative Candida versus bacterial mediastinitis: a case-matched comparative study.

  2021cites this paper
• Visible-light-driven photocatalytic disinfection of Aspergillus fumigatus under germinative biomorph: Efficiency and mechanism

  2021cites this paper
• Natural Compounds for Preventing Ear, Nose, and Throat-Related Oral Infections

  2021cites this paper
• Emerging Invasive Fungal Infections in Critically Ill Patients: Incidence, Outcomes and Prognosis Factors, a Case-Control Study

  2021influential citation
• Knowledge gaps in candidaemia/invasive candidiasis in haematological cancer patients.

  2020cites this paper
• Photodynamic inactivation of Candida albicans and Candida tropicalis with aluminum phthalocyanine chloride nanoemulsion.

  2020cites this paper
• Evaluation of (1 → 3)‐β‐D‐glucan assay for diagnosing paracoccidioidomycosis

  2020cites this paper
• The Mycobiome in Health and Disease: Emerging Concepts, Methodologies and Challenges

  2020cites this paper
• Evaluation of first-line therapies for the treatment of candidemia in ICU patients: A propensity score analysis.

  2020cites this paper
• Epidemiology of candidemia and impact of infectious disease consultation on survival and care

  2020cites this paper
• Legionellosis Complicated by Invasive Aspergillosis in a Patient With Rheumatoid Arthritis.

  2020cites this paper
• Unusual finding in Gram staining of blood cultures in a patient with prolonged febrile neutropenia and acute myeloid leukaemia

  2020cites this paper
• Epidemiology of Invasive Fungal Infections

  2020influential citation
• Unusual finding in Gram staining of blood cultures in a patient with prolonged febrile neutropenia and acute myeloid leukaemia.

  2020cites this paper
• Risk Prediction and Prognosis of Invasive Fungal Disease in Hematological Malignancies Patients Complicated with Bloodstream Infections

  2020cites this paper
• CMAR_A_238166 2167..2175

  2020cites this paper
• Invasive fungal diseases in patients with rheumatic diseases

  2020cites this paper
• Genotyping Reveals High Clonal Diversity and Widespread Genotypes of Candida Causing Candidemia at Distant Geographical Areas

  2020cites this paper
• Immunodiagnostic Assays for the Investigation of Fungal Outbreaks

  2020cites this paper
• Microbiology of hospital wastewater

  2020cites this paper
• An Overview of the Management of the Most Important Invasive Fungal Infections in Patients with Blood Malignancies

  2020cites this paper
• Evaluation of the potential virulence of Candida haemulonii species complex and Candida auris isolates in Caenorhabditis elegans as an in vivo model and correlation to their biofilm production capacity.

  2020cites this paper
• Case–Case Comparison of Candida auris Versus Other Candida Species Bloodstream Infections: Results of an Outbreak Investigation in Colombia

  2020cites this paper
• Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections

  2020cites this paper
• (1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial

  2020cites this paper
• British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of Candidiasis 2019

  2020cites this paper
• Mind the gaps: challenges in the clinical management of invasive candidiasis in critically ill patients

  2020influential citation
• CT features and clinical characteristics of invasive pulmonary aspergillosis complicated with hematopathy.

  2020cites this paper
• Allylic Selenocyanates as Antifungal Agents Against Pathogenic Candida Species

  2020cites this paper
• Iron Assimilation during Emerging Infections Caused by Opportunistic Fungi with emphasis on Mucorales and the Development of Antifungal Resistance

  2020cites this paper
• Multiplex PCR Based Strategy for Detection of Fungal Pathogen DNA in Patients with Suspected Invasive Fungal Infections

  2020cites this paper